Immunogenic Nanovesicle-Tandem-Augmented Chemoimmunotherapy via Efficient Cancer-Homing Delivery and Optimized Ordinal-Interval Regime.

Sun, Mengchi; Shi, Wen; Wu, Yuxia; He, Zhonggui; Sun, Jin; Cai, Shuang; Luo, Qiuhua.

Afiliação

Sun M; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, P. R. China.
Shi W; Department of Pharmacy, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China.
Wu Y; Department of Pharmacy, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China.
He Z; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, P. R. China.
Sun J; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, P. R. China.
Cai S; Department of Pharmacy, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China.
Luo Q; Department of Pharmacy, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P. R. China.

Adv Sci (Weinh) ; : e2205247, 2022 Dec 01.

Article em En | MEDLINE | ID: mdl-36453573